Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1998;29:1188-1193

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamamoto, M.
Right arrow Articles by Yamamoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamamoto, M.
Right arrow Articles by Yamamoto, K.

(Stroke. 1998;29:1188-1193.)
© 1998 American Heart Association, Inc.


Original Contributions

Differences in Cellular Responses to Mitogens in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease

Mari Yamamoto, PhD; Masaru Aoyagi, MD; Naomi Fukai, MD; Yoshiharu Matsushima, MD; Kiyotaka Yamamoto, PhD

From the Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology (M.Y., M.A., N.F., K.Y.), and the Department of Neurosurgery, Tokyo Medical and Dental University (M.A., Y.M.), Tokyo, Japan.

Correspondence to Kiyotaka Yamamoto, PhD, Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology, 35–2 Sakae-cho, Itabashi-ku, Tokyo 173, Japan. E-mail kyama{at}tmig.or.jp

Background and Purpose—Moyamoya disease is a progressive cerebrovascular occlusive disease affecting primarily children. The etiology remains unknown. We examined the chemotactic and proliferative activities of inflammatory cell products from arterial smooth muscle cells (SMCs) derived from moyamoya patients and compared them with those from control subjects.

Methods—We used 12 SMC strains from moyamoya patients and eight from control subjects. SMC migration was examined in a micro chemotaxis chamber. DNA synthesis was measured by an immunoperoxidase technique.

Results—Platelet-derived growth factor (PDGF)-BB markedly stimulated cell migration and DNA synthesis in control SMCs. PDGF-AA stimulated only DNA synthesis in control SMCs. In moyamoya SMCs, PDGF-AA and PDGF-BB stimulated cell migration but not DNA synthesis. Basic fibroblast growth factor had little migratory activity but stimulated DNA synthesis in moyamoya SMCs and control SMCs. Conversely, hepatocyte growth factor stimulated cell migration but not DNA synthesis in moyamoya SMCs and control SMCs. In contrast, interleukin-1ß (IL-1ß) significantly stimulated the migration and DNA synthesis of control SMCs, while it inhibited moyamoya SMC migration. The levels of IL-1ß–induced nitric oxide production did not differ between moyamoya SMCs and control SMCs, suggesting that IL-1ß inhibits the migration of moyamoya SMCs through a nitric oxide–independent pathway.

Conclusions—The differences in responses to PDGF and IL-1 in moyamoya SMCs are involved in the mechanism by which intimal thickening develops in moyamoya disease.


Key Words: cytokines • growth factors • moyamoya disease • muscle, smooth




This article has been cited by other articles:


Home page
StrokeHome page
M. Bonduel, M. Hepner, G. Sciuccati, A. F. Torres, S. Tenembaum, and G. de Veber
Prothrombotic Disorders in Children With Moyamoya Syndrome Editorial Comment
Stroke, August 1, 2001; 32(8): 1786 - 1792.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Yamamoto, M. Aoyagi, N. Fukai, Y. Matsushima, and K. Yamamoto
Increase in Prostaglandin E2 Production by Interleukin-1{beta} in Arterial Smooth Muscle Cells Derived From Patients With Moyamoya Disease
Circ. Res., November 12, 1999; 85(10): 912 - 918.
[Abstract] [Full Text] [PDF]